(800) 681-1379

LOGIN

Research

Research

Published CBD Research Articles

i

An Introduction to the Endogenous Cannabinoid System

Courtesy of the U.S. National Library of Medicine

i

Dermal and transdermal drug delivery systems: current and future prospects

Courtesy of the U.S. National Library of Medicine

i

Skin penetration and tissue permeation after topical administration of diclofenac

Courtesy of the U.S. National Library of Medicine

i

Evaluation of the cyclooxygenase inhibiting effects of six major cannabinoids isolated from Cannabis sativa

Courtesy of the U.S. National Library of Medicine

i

Cannabinoid-based drugs as anti-inflammatory therapeutics.

Courtesy of the U.S. National Library of Medicine

i

Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb

Courtesy of the U.S. National Library of Medicine

In this country, the sale of CBD products is expected to hit $4.75 billion in 2020, up 14% from last year. Within the professional dental  marketplace there are essentially no CBD products that dentists can provide to patients at their practice. There are products for consumers that may address a dental related issue, but it is the responsibility of the consumer to make the decision to purchase the product and the dentist or their office staff are not involved in the process.

Transdermal Relief Cream (TRC™) contains a higher concentration of CBD (2.5% transdermal cannabidiol) than those available at over-the-counter retail locations. It is a topical cream that is massaged on the skin in the TMD area of discomfort that acts quickly and provides temporary, long-lasting relief.

Our groundbreaking CBD product is an exciting new treatment for the dental industry. Learn about CBD as it’s used in the medical industry today, where it’s headed, and how we at Holistic Health Therapeutics harnessed the power of CBD to create TRC™.

TMD issues are the second most commonly occurring musculoskeletal conditions resulting in pain and disability after chronic low back pain.

It affects 5-12% of the population, approximately 10.5 million to 25.2 million people.

Become a

Provider

Contact Us For More Information

Contact Us For More Information